Rufini A - Search Results

1

A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients.

Paparella G, Stragà C, Pesenti N, Dal Molin V, Martorel GA, Merotto V, Genova C, Piazza A, Piccoli G, Panzeri E, Rufini A, Testi R, Martinuzzi A. Paparella G, et al. Among authors: rufini a. Children (Basel). 2024 Aug 9;11(8):958. doi: 10.3390/children11080958. Children (Basel). 2024. PMID: 39201893 Free PMC article.

2

Drug Repositioning in Friedreich Ataxia.

Rufini A, Malisan F, Condò I, Testi R. Rufini A, et al. Front Neurosci. 2022 Feb 9;16:814445. doi: 10.3389/fnins.2022.814445. eCollection 2022. Front Neurosci. 2022. PMID: 35221903 Free PMC article. Review.

3

Safety and efficacy of interferon γ in friedreich's ataxia.

Vavla M, D'Angelo MG, Arrigoni F, Toschi N, Peruzzo D, Gandossini S, Russo A, Diella E, Tirelli S, Salati R, Scarpazza P, Luffarelli R, Fortuni S, Rufini A, Condò I, Testi R, Martinuzzi A. Vavla M, et al. Among authors: rufini a. Mov Disord. 2020 Feb;35(2):370-371. doi: 10.1002/mds.27979. Epub 2020 Jan 13. Mov Disord. 2020. PMID: 31930551 No abstract available.

4

Sensitivity of Neuroimaging Indicators in Monitoring the Effects of Interferon Gamma Treatment in Friedreich's Ataxia.

Vavla M, Arrigoni F, Toschi N, Peruzzo D, D'Angelo MG, Gandossini S, Russo A, Diella E, Tirelli S, Salati R, Rufini A, Condo I, Testi R, Martinuzzi A. Vavla M, et al. Among authors: rufini a. Front Neurosci. 2020 Oct 9;14:872. doi: 10.3389/fnins.2020.00872. eCollection 2020. Front Neurosci. 2020. PMID: 33162876 Free PMC article.

5

Lipid signaling in CD95-mediated apoptosis.

Rufini A, Testi R. Rufini A, et al. Subcell Biochem. 2002;36:285-308. doi: 10.1007/0-306-47931-1_15. Subcell Biochem. 2002. PMID: 12037987 Review. No abstract available.

6

Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia.

Rufini A, Fortuni S, Arcuri G, Condò I, Serio D, Incani O, Malisan F, Ventura N, Testi R. Rufini A, et al. Hum Mol Genet. 2011 Apr 1;20(7):1253-61. doi: 10.1093/hmg/ddq566. Epub 2011 Jan 7. Hum Mol Genet. 2011. PMID: 21216878

7

Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.

Alfedi G, Luffarelli R, Condò I, Pedini G, Mannucci L, Massaro DS, Benini M, Toschi N, Alaimo G, Panarello L, Pacini L, Fortuni S, Serio D, Malisan F, Testi R, Rufini A. Alfedi G, et al. Among authors: rufini a. Mov Disord. 2019 Mar;34(3):323-334. doi: 10.1002/mds.27604. Epub 2019 Jan 9. Mov Disord. 2019. PMID: 30624801

8

Interferon Gamma Enhances Cytoprotective Pathways via Nrf2 and MnSOD Induction in Friedreich's Ataxia Cells.

Luffarelli R, Panarello L, Quatrana A, Tiano F, Fortuni S, Rufini A, Malisan F, Testi R, Condò I. Luffarelli R, et al. Among authors: rufini a. Int J Mol Sci. 2023 Aug 11;24(16):12687. doi: 10.3390/ijms241612687. Int J Mol Sci. 2023. PMID: 37628866 Free PMC article.

9

In vivo maturation of human frataxin.

Condò I, Ventura N, Malisan F, Rufini A, Tomassini B, Testi R. Condò I, et al. Among authors: rufini a. Hum Mol Genet. 2007 Jul 1;16(13):1534-40. doi: 10.1093/hmg/ddm102. Epub 2007 Apr 27. Hum Mol Genet. 2007. PMID: 17468497

10

E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia.

Benini M, Fortuni S, Condò I, Alfedi G, Malisan F, Toschi N, Serio D, Massaro DS, Arcuri G, Testi R, Rufini A. Benini M, et al. Among authors: rufini a. Cell Rep. 2017 Feb 21;18(8):2007-2017. doi: 10.1016/j.celrep.2017.01.079. Cell Rep. 2017. PMID: 28228265 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters